Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 13.5B | 12.6B | 19.5B | 14.9B |
| Cost of revenue | — | — | — | — |
| Gross profit | — | — | — | — |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | 3.1B | 3.3B | 3.3B | 3.1B |
| Other operating expenses | 67M | 92M | 43M | 52M |
| Operating income | — | — | — | — |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | — | — | — | — |
| Other income expense | 280M | -177M | 1.3B | 591M |
| Pretax income | 920M | -149M | 553M | 1.4B |
| Tax provision | 207M | -186M | 140M | 264M |
| Net income | 742M | 73M | 451M | 1.2B |
| Basic EPS | 2.0 | -0.2 | 1.2 | 3.3 |
| Diluted EPS | 2.0 | -0.2 | 1.2 | 3.3 |
| Basic average shares | 396.2M | 397.5M | 399.2M | 401.3M |
| Diluted average shares | 398.3M | 399.6M | 401.2M | 403.2M |
| EBITDA | — | — | — | — |
| Net income from continuing op. | 742M | 73M | 451M | 1.2B |
| Minority interests | -35M | -130M | -3M | 27M |
| Preferred stock dividends | 10M | -1M | 5M | 14M |